Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma
about
Plectin-1 as a novel biomarker for pancreatic cancer.Imaging in the era of molecular oncology.Molecular Targeted Intervention for Pancreatic CancerTissue proteomics in pancreatic cancer study: discovery, emerging technologies, and challengesPeptides as targeting probes against tumor vasculature for diagnosis and drug deliveryCXCR-4 Targeted, Short Wave Infrared (SWIR) Emitting Nanoprobes for Enhanced Deep Tissue Imaging and Micrometastatic Cancer Lesion Detection.Challenges of Pancreatic Cancer.Multiple Bacteriophage Selection Strategies for Improved Affinity of a Peptide Targeting ERBB2Quantification of pancreatic cancer proteome and phosphorylome: indicates molecular events likely contributing to cancer and activity of drug targetsPHASTpep: Analysis Software for Discovery of Cell-Selective Peptides via Phage Display and Next-Generation Sequencing.Imaging in pancreatic disease.High-Throughput Approaches to the Development of Molecular Imaging Agents.Plectin-1 as a Biomarker of Malignant Progression in Intraductal Papillary Mucinous Neoplasms: A Multicenter Study.Development of target-specific liposomes for delivering small molecule drugs after reperfused myocardial infarction.Combining in Vitro Diagnostics with in Vivo Imaging for Earlier Detection of Pancreatic Ductal Adenocarcinoma: Challenges and Solutions.Imaging of targeted lipid microbubbles to detect cancer cells using third harmonic generation microscopy.Unexpected gain of function for the scaffolding protein plectin due to mislocalization in pancreatic cancer.Plectin-1 is a biomarker of malignant pancreatic intraductal papillary mucinous neoplasms.Plectin-1 Targeted AAV Vector for the Molecular Imaging of Pancreatic Cancer.Techniques for molecular imaging probe designA functional proteomic method for biomarker discovery.Molecular imaging agents: impact on diagnosis and therapeutics in oncologyTargeted nanoparticles in imaging: paving the way for personalized medicine in the battle against cancer.Molecular imaging of pancreatic cancer in an animal model using targeted multifunctional nanoparticles.Combinatorial peptide libraries: mining for cell-binding peptides.Peptidic tumor targeting agents: the road from phage display peptide selections to clinical applications.Phage display in molecular imaging and diagnosis of cancer.Nanodrug delivery systems: a promising technology for detection, diagnosis, and treatment of cancer.Visualization of gene expression in the live subject using the Na/I symporter as a reporter gene: applications in biotherapyTargeting of drugs and nanoparticles to tumors.Proteomics in pancreatic cancer research.Phage display and molecular imaging: expanding fields of vision in living subjects.Enabling individualized therapy through nanotechnologyDextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy.A fluorescent protein scaffold for presenting structurally constrained peptides provides an effective screening system to identify high affinity target-binding peptides.The RON-receptor regulates pancreatic cancer cell migration through phosphorylation-dependent breakdown of the hemidesmosome.Affinity peptide developed by phage display selection for targeting gastric cancer.Molecular imaging of Cathepsin E-positive tumors in mice using a novel protease-activatable fluorescent probe.Optimizing nanomedicine pharmacokinetics using physiologically based pharmacokinetics modelling.Incidentally discovered pancreatic intraepithelial neoplasia: what is its clinical significance?
P2860
Q24615622-A75A2D5A-0146-4EA8-B03C-31E427A50A8AQ24650949-C74A72DB-250F-4F71-826B-E9925470D16BQ26798453-3E8E7D26-0656-4EBA-963B-94BE768CCFB6Q26824034-175964A7-B301-4708-ACA5-DA9D318D52AFQ27024850-1450D3B8-B78C-4D61-9782-FF47ED4A6603Q27330200-650AC703-A117-4975-B075-D8C893006AE8Q28080671-9ED8CB92-C3DC-4036-8474-983004DA9072Q28393445-29798C2E-4C7B-4FDE-805E-80B6843EEA11Q28541545-E05A86B1-B897-4566-AB60-1884843A9C3BQ28552108-692C6D45-75AB-4EBF-87FA-EB3DD3161FC3Q30275458-9AF63140-FC1B-4A27-909E-701EC2AE704FQ30275493-1A1222C9-3255-4181-929C-1F57E338ECF1Q30276945-400F9EAD-BBF2-4AC9-9F1E-8CDE775C004CQ30279093-C49DD7B9-7ADB-460E-807E-16DB6F848B02Q30368922-317AAA6F-B191-4265-BB5B-4825D5A05764Q30378401-AFF77A8E-79F8-4B43-87FE-9AC9B15E7BD3Q30412956-AF0BAA2A-55C1-4E89-A404-A229E175FF81Q30416761-FD3AFEB6-5106-431F-909E-04807BAD569DQ30419813-CAC02705-9EF3-4AAD-9D67-F61536090004Q30423734-4ED8195C-C027-49DD-AD5E-E6A68DACF604Q30431185-2A59466E-ED8C-48CA-8CC4-E224BA1BE6FCQ30433423-FB20A3A9-8AE0-4D8B-9661-4E326DC381D3Q30455820-2A1437B1-3AF7-457F-9CE5-ED071182B156Q30539738-73F72AC0-6307-40AD-8340-B2F8FF5AD34DQ31144876-BDC1C0DC-BACC-4C16-A36B-ED78AB7A8CA3Q33520512-743CBB74-C059-4BD3-81E0-2B35C2225B3CQ33532734-B13E2E8C-8D6A-43E1-8541-F4275BB0B9DAQ33681168-30F7E1DB-A721-4C69-B0E5-875A72721E5BQ33690729-CA606BED-C911-4062-AB14-262802772D66Q33751710-15DED1E4-B727-45CB-92D9-26AD944AF496Q33791981-501B0684-EAC8-444A-812C-84E896F18344Q33849788-FE3099DB-93D6-448F-AD72-86C9F62293C3Q33917755-AB15B626-61E8-4DDA-9A8E-261195A12CFDQ33929151-D98DEC9A-2605-4310-9F20-71FAE018CDFBQ33989074-19332A5D-963A-4CF8-A7D0-20264CE94794Q34139704-2909BDFA-41A9-4DFD-A9DB-4BE85AE0526AQ34259540-E2E0687B-9586-468C-8CE5-D49C2E4F819DQ34392691-C6D07496-0DA4-4116-A04A-ED2DDCFDAD67Q34571360-3FA6EC67-6AAC-43CD-B610-33F8D9D9EADBQ34652902-2C74D1C0-5228-428F-988C-45ECB03AC5EF
P2860
Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma
@ast
Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma
@en
Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma
@en-gb
Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma
@nl
type
label
Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma
@ast
Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma
@en
Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma
@en-gb
Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma
@nl
altLabel
Targeted Nanoparticles for Imaging Incipient Pancreatic Ductal Adenocarcinoma
@en
prefLabel
Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma
@ast
Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma
@en
Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma
@en-gb
Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma
@nl
P2093
P2860
P3181
P1433
P1476
Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma
@en
P2093
Herlen Alencar
Justin Berger
Kimberly A Kelly
Rajesh Anbazhagan
Ronald A Depinho
Sushma Gurumurthy
Umar Mahmood
P2860
P3181
P356
10.1371/JOURNAL.PMED.0050085
P407
P577
2008-04-15T00:00:00Z